Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Inappropriate schedule of product administration, Metabolic function test
Clinical narrative: Pfizer Covid-19 vaccines (GRAY CAP) that were administered a month sooner; 4 months instead of 5 months from when it was due; CBC except his red blood cells were 5.82 x10e/ul; On the CMP his BUN Creatinine ratio was at 8; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program. Other Case identifier(s): US-PFIZER INC-202200148709 (Pfizer).  A 19 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 25Jan2022 14:00 (Lot number: FK9729, Expiration Date: 03May2022) at the age of 19 years as dose 3, 0.3ml [booster] [tris], single for covid-19 immunisation. Relevant medical history included: "Pulmonary embolism" (unspecified if ongoing); "asthma" (unspecified if ongoing); "Nausea", start date: 20Jan2022, stop date: 23Jan2022; "vomiting", start date: 20Jan2022, stop date: 23Jan2022. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), administration date: 22Apr2021, when the patient was 18 years old, for Covid-19 immunization; Bnt162b2 (dose 2, single), administration date: 26Sep2021, when the patient was 19 years old, for Covid-19 immunization, reaction(s): "asthma". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 25Jan2022, outcome "unknown", described as "Pfizer Covid-19 vaccines (GRAY CAP) that were administered a month sooner; 4 months instead of 5 months from when it was due"; FULL BLOOD COUNT (non-serious) with onset 25Jan2022, outcome "unknown", described as "CBC except his red blood cells were 5.82 x10e/ul"; BLOOD UREA (non-serious) with onset 25Jan2022, outcome "unknown", described as "On the CMP his BUN Creatinine ratio was at 8". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The did not patient provide information to you regarding the reported adverse events with the use of the product. The patient did not receive any other vaccines within four weeks prior to the vaccination. Caller was an HCP working in an office where another HCP gave the booster shot at 4 months instead of at the 5-month interval for the gray top Covid vaccine. The recipient was a 19-year-old male. Caller stated she tried to report it yesterday, but was on hold for 1.5 hours, so this was first report. Caller stated the first dose of Covid Vaccine was given on 22Apr2021 and second dose was given on 26Sep2021. The first and second dose were not given by caller's facility. History: It was noted in patient chart that he had a previous diagnosis of Pulmonary Embolism. The patient was new to caller's office in Jul2021. At that time, he was seen for hospital follow up for asthma attack and pulmonary embolism. The patient had an asthma exacerbation a few weeks prior and was treated in ER and sent home. Caller clarified that the patient was not admitted to the hospital. Caller is not sure how long ago the pulmonary embolism was based on the information she has there. The patient was taking Eliquis for the pulmonary embolism. He was on 5mg once a day. It doesn't look like it was refilled. It was notated when he was seen yesterday, 25Jan2022, that he was no longer taking it. Investigations: On 25Jan2022 a CBC and CMP was done about 20 to 30 minutes after booster was given. Everything was normal on the CBC except his red blood cells were 5.82 x10e/ul. On the CMP his BUN Creatinine ratio was at 8, but everything else was normal. Caller states there is no units listed for the BUN Creatinine ratio. Family medical history relevant to AE(s) was none. Caller talked to the provider via video chat regarding the Eliquis. The provider said the patient had not been taking Eliquis for several months prior to coming yesterday, 25Jan2022. Caller asked the provider if she had any concerns about the patient getting the booster one month early and she said no.  No follow-up attempts are possible. No further information is expected.